Collaboration Details

Print  Close


Title of Collaborative Activity:

American Academy of Pediatrics (AAP) Committee on Drugs

Description of Collaborative Activity:

The AAP Committee on Drugs reviews all aspects of pediatric pharmacology, including drug indications, contraindications, absorption rates, routes of administration, dosing, use precautions, and mode of action as they apply to children. The Committee also advises the Board of Directors in matters related to drug labeling, safety, and efficacy for both prescription and over-the-counter drugs; monitors federal legislation related to the drug approval process; and promotes the need for expanded pediatric drug trials.

Type of Collaborative Activity:

Committee, Advisory Group, or Work Group

Year the Collaborative Activity Originated:

Unknown

NIH Participating Institutes/Centers/Office of the Director:

NICHD

HHS Agency Collaborators on this Activity:

FDA